When was OriGen Biomedical founded?

OriGen Biomedical was founded in 1996.

Where is OriGen Biomedical located?

OriGen Biomedical is headquartered in Austin, United States. It is registered at Austin, Texas.

How many employees does OriGen Biomedical have?

As of Apr 30, 2026, the latest employee count at OriGen Biomedical is 100.

Is OriGen Biomedical a funded company?

OriGen Biomedical is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does OriGen Biomedical rank among its competitors?

OriGen Biomedical ranks 4th amongst 21 active competitors, of which 4 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Boreas Monitoring Solutions, which secured $85K in Jun, 2023.

Who are the top competitors of OriGen Biomedical?

OriGen Biomedical's top competitors include Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology. Among them, Boreas Monitoring Solutions secured the most recent funding round in June, 2023.

OriGen Biomedical - 2026 Company Profile & Competitors

OriGen Biomedical is an unfunded company based in Austin (United States), founded in 1996. It operates as an Innovating cryopreservation and cell culture solutions for regenerative medicine. OriGen Biomedical has not raised any funding yet. The company has 21 active competitors, including 4 funded and 5 that have exited. Its top competitors include companies like Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology.

Company Details

Innovating cryopreservation and cell culture solutions for regenerative medicine. They are dedicated to producing innovative medical products that improve people’s lives. They focus on providing a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Their products are designed with the patient and user in mind, and they strive to maintain excellent customer service to ensure that patient care is the priority. They are a medical device manufacturer specializing in single-use disposables within cell and gene therapy, supporting transformational therapies across the world. They offer cryopreservation bags, cell culture bags, freezing solutions, and accessory sets. They are committed to user-inspired design, quality, and customer satisfaction, offering tailored solutions for cell-based immunotherapy and tissue engineering. They hold ISO and MDSAP certifications, ensuring high-quality products for the regenerative medicine field.

Website: www.origen.com/
Phone Number: +1 **********
Registered Address: Austin, Texas

Key Metrics

Founded Year

1996

Location

Austin, United States

Stage

Unfunded

Ranked

4^th among 21 active competitors

Employee Count

100 as on Apr 30, 2026

Similar Companies

Stirling Ultracold & 19 more

View OriGen Biomedical's full profile

OriGen Biomedical is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ORIGEN BIOMEDICAL, INC. CIN: 521824990 , United States, Active	Dec 26, 999	-	170 (As on Dec 31, 2024)	-

OriGen Biomedical has not raised any funding rounds yet.

OriGen Biomedical's employee count trend

OriGen Biomedical has 100 employees as of Apr 26. Here is OriGen Biomedical's employee count trend over the years:

Employee count trend for OriGen Biomedical

Uncover OriGen Biomedical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OriGen Biomedical include Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology. Here is the list of Top 10 competitors of OriGen Biomedical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Stirling Ultracold 2009, Athens (United States), Acquired	Manufacturer of freezer for storage and preservation	$8.7M	Ohio Innovation Fund, Square 1 Bank & 4 others	66/100
2nd	PanTHERA CryoSolutions 2018, Edmonton (Canada), Acquired	Provider of a platform for cell cryopreservation	$6M	Casdin Capital, BioLife Solutions & 1 others	53/100
3rd	Genepoint Biological Technology 2015, Shanghai (China), Series D	Platform for cryostorage and long-term preservation	$48.3M	NLVC, New Hope Group & 8 others	39/100
4th	OriGen Biomedical 1996, Austin (United States), Unfunded	Innovating cryopreservation and cell culture solutions for regenerative medicine	-	-	29/100
5th	Montana Instruments 2008, Bozeman (United States), Acquired	Cryogenic solutions provider accelerating quantum discovery with reliable, low-temperature environments	-	-	34/100
6th	Cell Matters 2017, Liege (Belgium), Series A	CDMO focused on manufacturing of cell therapy products	$872K	Paip investissements, Noshaq & 2 others	34/100
7th	Cryopal 1968, Bussy Saint Georges (France), Funding Raised	Provider of cryo-preservation equipment and services	-	Initiative & Finance	30/100
8th	Cryo Store 1999, Joure (Netherlands), Unfunded	Tools for biostorage	-	-	27/100
9th	MFC Global 2013, Rishon Lezion (Israel), Unfunded	Developer of a device for cryopreservation of spermatozoa	-	-	26/100
10th	Boreas Monitoring Solutions 2019, Wilmington (United States), Seed	Developer of weight-based monitoring systems for cryotanks used in laboratory settings	$85K	-	25/100